A new trading day began on Friday, with Pacific Biosciences of California Inc (NASDAQ: PACB) stock price up 8.52% from the previous day of trading, before settling in for the closing price of $1.76. PACB’s price has ranged from $1.16 to $10.65 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 24.48% over the last five years. Meanwhile, its annual earnings per share averaged -12.49%. With a float of $262.20 million, this company’s outstanding shares have now reached $267.74 million.
The firm has a total of 796 workers. Let’s measure their productivity. In terms of profitability, gross margin is 18.12%, operating margin of -215.33%, and the pretax margin is -228.11%.
Pacific Biosciences of California Inc (PACB) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Pacific Biosciences of California Inc is 4.26%, while institutional ownership is 81.74%. The most recent insider transaction that took place on Sep 30 ’24, was worth 34,065. In this transaction an insider of this company sold 19,782 shares at a rate of $1.72, taking the stock ownership to the 695,654 shares. Before that another transaction happened on Sep 30 ’24, when Company’s Officer proposed sale 19,782 for $1.72, making the entire transaction worth $34,061.
Pacific Biosciences of California Inc (PACB) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -12.49% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -1.00% during the next five years compared to -9.76% drop over the previous five years of trading.
Pacific Biosciences of California Inc (NASDAQ: PACB) Trading Performance Indicators
Here are Pacific Biosciences of California Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.28.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.68 in one year’s time.
Technical Analysis of Pacific Biosciences of California Inc (PACB)
Analysing the last 5-days average volume posted by the [Pacific Biosciences of California Inc, PACB], we can find that recorded value of 7.88 million was lower than the volume posted last year of 9.62 million. As of the previous 9 days, the stock’s Stochastic %D was 66.30%. Additionally, its Average True Range was 0.22.
During the past 100 days, Pacific Biosciences of California Inc’s (PACB) raw stochastic average was set at 44.14%, which indicates a significant increase from 35.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 113.36% in the past 14 days, which was lower than the 123.19% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.9056, while its 200-day Moving Average is $2.2585. Now, the first resistance to watch is $2.0133. This is followed by the second major resistance level at $2.1167. The third major resistance level sits at $2.2433. If the price goes on to break the first support level at $1.7833, it is likely to go to the next support level at $1.6567. Now, if the price goes above the second support level, the third support stands at $1.5533.
Pacific Biosciences of California Inc (NASDAQ: PACB) Key Stats
With a market capitalization of 567.66 million, the company has a total of 273,864K Shares Outstanding. Currently, annual sales are 200,520 K while annual income is -306,740 K. The company’s previous quarter sales were 39,970 K while its latest quarter income was -60,730 K.
